nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Sorafenib—liver cancer	0.518	1	CbGbCtD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.021	0.0853	CbGpPWpGaD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.0151	0.0613	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.0109	0.0441	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—UGDH—liver cancer	0.00989	0.0401	CbGpPWpGaD
Abacavir—UGT1A1—Glucuronidation—UGDH—liver cancer	0.00874	0.0354	CbGpPWpGaD
Abacavir—UGT1A1—Glucuronidation—UGDH—liver cancer	0.00709	0.0287	CbGpPWpGaD
Abacavir—Lymphopenia—Sorafenib—liver cancer	0.0063	0.0267	CcSEcCtD
Abacavir—UGT1A1—Heme degradation—HMOX1—liver cancer	0.00593	0.024	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00593	0.024	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—NR1H4—liver cancer	0.00578	0.0234	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTA3—liver cancer	0.00568	0.023	CbGpPWpGaD
Abacavir—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00548	0.0233	CcSEcCtD
Abacavir—ADH6—Biological oxidations—GSTA4—liver cancer	0.0052	0.0211	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTA2—liver cancer	0.00506	0.0205	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTA1—liver cancer	0.00489	0.0198	CbGpPWpGaD
Abacavir—Lactic acidosis—Epirubicin—liver cancer	0.00488	0.0207	CcSEcCtD
Abacavir—ADH6—Biological oxidations—NAT2—liver cancer	0.00483	0.0196	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTA1—liver cancer	0.0047	0.019	CbGpPWpGaD
Abacavir—Lactic acidosis—Doxorubicin—liver cancer	0.00451	0.0192	CcSEcCtD
Abacavir—Oropharyngeal discomfort—Sorafenib—liver cancer	0.00443	0.0188	CcSEcCtD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00426	0.0173	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—HPGDS—liver cancer	0.00386	0.0157	CbGpPWpGaD
Abacavir—Rhabdomyolysis—Sorafenib—liver cancer	0.00364	0.0155	CcSEcCtD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00345	0.014	CbGpPWpGaD
Abacavir—Blood bilirubin increased—Sorafenib—liver cancer	0.00341	0.0145	CcSEcCtD
Abacavir—Sensitisation—Epirubicin—liver cancer	0.00334	0.0141	CcSEcCtD
Abacavir—ADH6—Biological oxidations—CYP2E1—liver cancer	0.00315	0.0128	CbGpPWpGaD
Abacavir—Influenza like illness—Sorafenib—liver cancer	0.00313	0.0133	CcSEcCtD
Abacavir—Sensitisation—Doxorubicin—liver cancer	0.00309	0.0131	CcSEcCtD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00307	0.0124	CbGpPWpGaD
Abacavir—Neuropathy—Sorafenib—liver cancer	0.00303	0.0128	CcSEcCtD
Abacavir—Drug hypersensitivity—Epirubicin—liver cancer	0.00296	0.0125	CcSEcCtD
Abacavir—Opportunistic infection—Epirubicin—liver cancer	0.00296	0.0125	CcSEcCtD
Abacavir—Mouth ulceration—Sorafenib—liver cancer	0.00291	0.0124	CcSEcCtD
Abacavir—ADH6—Biological oxidations—GGT1—liver cancer	0.00289	0.0117	CbGpPWpGaD
Abacavir—Drug hypersensitivity—Doxorubicin—liver cancer	0.00274	0.0116	CcSEcCtD
Abacavir—Opportunistic infection—Doxorubicin—liver cancer	0.00274	0.0116	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—UGDH—liver cancer	0.00267	0.0108	CbGpPWpGaD
Abacavir—Hepatic failure—Sorafenib—liver cancer	0.0026	0.011	CcSEcCtD
Abacavir—ADH6—Biological oxidations—GSTP1—liver cancer	0.0026	0.0105	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—HMOX1—liver cancer	0.00258	0.0104	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—liver cancer	0.00239	0.00967	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—liver cancer	0.00236	0.00956	CbGpPWpGaD
Abacavir—Lymphopenia—Epirubicin—liver cancer	0.00233	0.00988	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—GSTA2—liver cancer	0.0023	0.00931	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—liver cancer	0.00229	0.00929	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP1A1—liver cancer	0.00226	0.00917	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—CYP1A1—liver cancer	0.00217	0.00881	CbGpPWpGaD
Abacavir—Lymphopenia—Doxorubicin—liver cancer	0.00215	0.00914	CcSEcCtD
Abacavir—Abdominal pain upper—Sorafenib—liver cancer	0.00214	0.00907	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00211	0.00894	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00211	0.00894	CcSEcCtD
Abacavir—UGT1A1—Irinotecan Pathway—APC—liver cancer	0.00208	0.00844	CbGpPWpGaD
Abacavir—Gastritis—Sorafenib—liver cancer	0.00207	0.00878	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00206	0.00875	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.002	0.00812	CbGpPWpGaD
Abacavir—Pancreatitis—Sorafenib—liver cancer	0.00198	0.00841	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.00195	0.00792	CbGpPWpGaD
Abacavir—Abdominal discomfort—Sorafenib—liver cancer	0.00194	0.00822	CcSEcCtD
Abacavir—Neutropenia—Sorafenib—liver cancer	0.00189	0.00802	CcSEcCtD
Abacavir—Pneumonia—Sorafenib—liver cancer	0.00181	0.00769	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00179	0.00758	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—DNAJB1—liver cancer	0.00178	0.00722	CbGpPWpGaD
Abacavir—Acute coronary syndrome—Sorafenib—liver cancer	0.00178	0.00754	CcSEcCtD
Abacavir—Renal failure—Sorafenib—liver cancer	0.00177	0.00752	CcSEcCtD
Abacavir—Myocardial infarction—Sorafenib—liver cancer	0.00177	0.0075	CcSEcCtD
Abacavir—Neuropathy peripheral—Sorafenib—liver cancer	0.00177	0.0075	CcSEcCtD
Abacavir—Stomatitis—Sorafenib—liver cancer	0.00176	0.00746	CcSEcCtD
Abacavir—Hepatobiliary disease—Sorafenib—liver cancer	0.00171	0.00723	CcSEcCtD
Abacavir—ADH6—Metabolism—UGDH—liver cancer	0.00169	0.00686	CbGpPWpGaD
Abacavir—Hepatomegaly—Epirubicin—liver cancer	0.00168	0.00714	CcSEcCtD
Abacavir—Connective tissue disorder—Sorafenib—liver cancer	0.00159	0.00675	CcSEcCtD
Abacavir—ADH6—Metabolism—EPT1—liver cancer	0.00159	0.00645	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—UGDH—liver cancer	0.00156	0.00633	CbGpPWpGaD
Abacavir—Hepatomegaly—Doxorubicin—liver cancer	0.00156	0.00661	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTA3—liver cancer	0.00153	0.00622	CbGpPWpGaD
Abacavir—Erythema multiforme—Sorafenib—liver cancer	0.00153	0.00649	CcSEcCtD
Abacavir—ADH6—Metabolism—TAT—liver cancer	0.00151	0.00611	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00148	0.006	CbGpPWpGaD
Abacavir—Immune system disorder—Sorafenib—liver cancer	0.00146	0.0062	CcSEcCtD
Abacavir—Alopecia—Sorafenib—liver cancer	0.00143	0.00607	CcSEcCtD
Abacavir—Blood disorder—Epirubicin—liver cancer	0.00143	0.00605	CcSEcCtD
Abacavir—Malnutrition—Sorafenib—liver cancer	0.00141	0.00598	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTA4—liver cancer	0.0014	0.00569	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTA2—liver cancer	0.00137	0.00554	CbGpPWpGaD
Abacavir—Blood disorder—Doxorubicin—liver cancer	0.00132	0.0056	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTA1—liver cancer	0.00132	0.00535	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—NAT2—liver cancer	0.0013	0.00529	CbGpPWpGaD
Abacavir—Anaemia—Sorafenib—liver cancer	0.0013	0.00553	CcSEcCtD
Abacavir—Leukopenia—Sorafenib—liver cancer	0.00126	0.00535	CcSEcCtD
Abacavir—Blood bilirubin increased—Epirubicin—liver cancer	0.00126	0.00534	CcSEcCtD
Abacavir—Creatinine increased—Epirubicin—liver cancer	0.00125	0.00531	CcSEcCtD
Abacavir—Cough—Sorafenib—liver cancer	0.00123	0.00522	CcSEcCtD
Abacavir—Inflammation—Epirubicin—liver cancer	0.00123	0.00521	CcSEcCtD
Abacavir—Musculoskeletal pain—Epirubicin—liver cancer	0.00121	0.00512	CcSEcCtD
Abacavir—Arthralgia—Sorafenib—liver cancer	0.0012	0.00509	CcSEcCtD
Abacavir—Myalgia—Sorafenib—liver cancer	0.0012	0.00509	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00119	0.00505	CcSEcCtD
Abacavir—Abnormal dreams—Epirubicin—liver cancer	0.00118	0.00499	CcSEcCtD
Abacavir—Blood bilirubin increased—Doxorubicin—liver cancer	0.00117	0.00494	CcSEcCtD
Abacavir—Creatinine increased—Doxorubicin—liver cancer	0.00116	0.00491	CcSEcCtD
Abacavir—Influenza like illness—Epirubicin—liver cancer	0.00116	0.00491	CcSEcCtD
Abacavir—Anaphylactic shock—Sorafenib—liver cancer	0.00115	0.00488	CcSEcCtD
Abacavir—Infection—Sorafenib—liver cancer	0.00114	0.00485	CcSEcCtD
Abacavir—Inflammation—Doxorubicin—liver cancer	0.00114	0.00482	CcSEcCtD
Abacavir—Nervous system disorder—Sorafenib—liver cancer	0.00113	0.00478	CcSEcCtD
Abacavir—Thrombocytopenia—Sorafenib—liver cancer	0.00113	0.00478	CcSEcCtD
Abacavir—Aplastic anaemia—Epirubicin—liver cancer	0.00112	0.00474	CcSEcCtD
Abacavir—Neuropathy—Epirubicin—liver cancer	0.00112	0.00474	CcSEcCtD
Abacavir—Skin disorder—Sorafenib—liver cancer	0.00112	0.00474	CcSEcCtD
Abacavir—Musculoskeletal pain—Doxorubicin—liver cancer	0.00112	0.00473	CcSEcCtD
Abacavir—Anorexia—Sorafenib—liver cancer	0.0011	0.00465	CcSEcCtD
Abacavir—Abnormal dreams—Doxorubicin—liver cancer	0.00109	0.00462	CcSEcCtD
Abacavir—Mouth ulceration—Epirubicin—liver cancer	0.00108	0.00457	CcSEcCtD
Abacavir—Influenza like illness—Doxorubicin—liver cancer	0.00107	0.00454	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00105	0.00444	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—HPGDS—liver cancer	0.00104	0.00423	CbGpPWpGaD
Abacavir—Aplastic anaemia—Doxorubicin—liver cancer	0.00103	0.00439	CcSEcCtD
Abacavir—Neuropathy—Doxorubicin—liver cancer	0.00103	0.00439	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.00103	0.00416	CbGpPWpGaD
Abacavir—Dyspnoea—Sorafenib—liver cancer	0.00103	0.00435	CcSEcCtD
Abacavir—ADH6—Metabolism—GLUL—liver cancer	0.00102	0.00415	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CPT1B—liver cancer	0.00102	0.00415	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTA3—liver cancer	0.00102	0.00415	CbGpPWpGaD
Abacavir—Lymphadenopathy—Epirubicin—liver cancer	0.00101	0.0043	CcSEcCtD
Abacavir—Decreased appetite—Sorafenib—liver cancer	0.001	0.00424	CcSEcCtD
Abacavir—Mouth ulceration—Doxorubicin—liver cancer	0.000997	0.00423	CcSEcCtD
Abacavir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000993	0.00421	CcSEcCtD
Abacavir—Fatigue—Sorafenib—liver cancer	0.000992	0.00421	CcSEcCtD
Abacavir—ADH6—Metabolism—NR1H4—liver cancer	0.000988	0.00401	CbGpPWpGaD
Abacavir—Pain—Sorafenib—liver cancer	0.000984	0.00417	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTA3—liver cancer	0.000972	0.00394	CbGpPWpGaD
Abacavir—Hepatic failure—Epirubicin—liver cancer	0.000962	0.00408	CcSEcCtD
Abacavir—Gastrointestinal pain—Sorafenib—liver cancer	0.00094	0.00399	CcSEcCtD
Abacavir—Lymphadenopathy—Doxorubicin—liver cancer	0.000938	0.00398	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GSTA4—liver cancer	0.000936	0.00379	CbGpPWpGaD
Abacavir—Urticaria—Sorafenib—liver cancer	0.000914	0.00388	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—NR1H4—liver cancer	0.000913	0.0037	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTA2—liver cancer	0.000912	0.0037	CbGpPWpGaD
Abacavir—Abdominal pain—Sorafenib—liver cancer	0.000909	0.00386	CcSEcCtD
Abacavir—Body temperature increased—Sorafenib—liver cancer	0.000909	0.00386	CcSEcCtD
Abacavir—ADK—Metabolism—UGDH—liver cancer	0.000903	0.00366	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTA3—liver cancer	0.000898	0.00364	CbGpPWpGaD
Abacavir—Hepatic failure—Doxorubicin—liver cancer	0.00089	0.00378	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTA4—liver cancer	0.000889	0.0036	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTA3—liver cancer	0.000885	0.00359	CbGpPWpGaD
Abacavir—Lethargy—Epirubicin—liver cancer	0.000883	0.00374	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GSTA1—liver cancer	0.00088	0.00357	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTA2—liver cancer	0.000866	0.00351	CbGpPWpGaD
Abacavir—Migraine—Epirubicin—liver cancer	0.000851	0.00361	CcSEcCtD
Abacavir—ADK—Metabolism—EPT1—liver cancer	0.000849	0.00344	CbGpPWpGaD
Abacavir—Hypersensitivity—Sorafenib—liver cancer	0.000847	0.00359	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTA1—liver cancer	0.000836	0.00339	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NAT2—liver cancer	0.000826	0.00335	CbGpPWpGaD
Abacavir—Asthenia—Sorafenib—liver cancer	0.000825	0.0035	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTA4—liver cancer	0.000821	0.00333	CbGpPWpGaD
Abacavir—Lethargy—Doxorubicin—liver cancer	0.000817	0.00346	CcSEcCtD
Abacavir—Pruritus—Sorafenib—liver cancer	0.000814	0.00345	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—liver cancer	0.00081	0.00344	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTA4—liver cancer	0.00081	0.00328	CbGpPWpGaD
Abacavir—ADK—Metabolism—TAT—liver cancer	0.000805	0.00326	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTA2—liver cancer	0.0008	0.00324	CbGpPWpGaD
Abacavir—Liver function test abnormal—Epirubicin—liver cancer	0.000798	0.00339	CcSEcCtD
Abacavir—ADH6—Metabolism—ALDOB—liver cancer	0.000792	0.00321	CbGpPWpGaD
Abacavir—Abdominal pain upper—Epirubicin—liver cancer	0.00079	0.00335	CcSEcCtD
Abacavir—Migraine—Doxorubicin—liver cancer	0.000788	0.00334	CcSEcCtD
Abacavir—Diarrhoea—Sorafenib—liver cancer	0.000787	0.00334	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GGT1—liver cancer	0.000781	0.00316	CbGpPWpGaD
Abacavir—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000779	0.0033	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000779	0.0033	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—NFE2L2—liver cancer	0.000776	0.00314	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTA1—liver cancer	0.000772	0.00313	CbGpPWpGaD
Abacavir—Gastritis—Epirubicin—liver cancer	0.000765	0.00325	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—NAT2—liver cancer	0.000763	0.00309	CbGpPWpGaD
Abacavir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000763	0.00324	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—liver cancer	0.000763	0.00324	CcSEcCtD
Abacavir—Dizziness—Sorafenib—liver cancer	0.000761	0.00323	CcSEcCtD
Abacavir—ADH6—Metabolism—CRABP1—liver cancer	0.000756	0.00306	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—NAT2—liver cancer	0.000753	0.00305	CbGpPWpGaD
Abacavir—Blood creatinine increased—Doxorubicin—liver cancer	0.00075	0.00318	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—TGFA—liver cancer	0.00074	0.003	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GPX3—liver cancer	0.00074	0.003	CbGpPWpGaD
Abacavir—Liver function test abnormal—Doxorubicin—liver cancer	0.000739	0.00313	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—liver cancer	0.000733	0.00311	CcSEcCtD
Abacavir—Vomiting—Sorafenib—liver cancer	0.000731	0.0031	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—liver cancer	0.000731	0.0031	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—SERPINA1—liver cancer	0.000729	0.00295	CbGpPWpGaD
Abacavir—Rash—Sorafenib—liver cancer	0.000725	0.00308	CcSEcCtD
Abacavir—Dermatitis—Sorafenib—liver cancer	0.000724	0.00307	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000721	0.00306	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000721	0.00306	CcSEcCtD
Abacavir—Headache—Sorafenib—liver cancer	0.000721	0.00306	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—liver cancer	0.000719	0.00305	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—liver cancer	0.000708	0.003	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000706	0.00299	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—liver cancer	0.000706	0.00299	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—liver cancer	0.000701	0.00284	CbGpPWpGaD
Abacavir—Neutropenia—Epirubicin—liver cancer	0.000699	0.00296	CcSEcCtD
Abacavir—Nausea—Sorafenib—liver cancer	0.000683	0.0029	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—liver cancer	0.000678	0.00288	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—liver cancer	0.000674	0.00286	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—liver cancer	0.00067	0.00284	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—liver cancer	0.000665	0.00282	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000661	0.0028	CcSEcCtD
Abacavir—ADH6—Metabolism—HPGDS—liver cancer	0.00066	0.00268	CbGpPWpGaD
Abacavir—Renal failure—Epirubicin—liver cancer	0.000655	0.00278	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—liver cancer	0.000653	0.00277	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—liver cancer	0.00065	0.00276	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—liver cancer	0.000648	0.00275	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—liver cancer	0.000647	0.00274	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—liver cancer	0.000644	0.00261	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GPX3—liver cancer	0.00064	0.00259	CbGpPWpGaD
Abacavir—Hepatobiliary disease—Epirubicin—liver cancer	0.00063	0.00267	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—liver cancer	0.000624	0.00265	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—liver cancer	0.00062	0.00263	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000611	0.00259	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—HPGDS—liver cancer	0.00061	0.00247	CbGpPWpGaD
Abacavir—Renal failure—Doxorubicin—liver cancer	0.000606	0.00257	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—liver cancer	0.000604	0.00256	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—liver cancer	0.000601	0.00255	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—liver cancer	0.000599	0.00254	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—liver cancer	0.000598	0.00254	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—liver cancer	0.000594	0.00252	CcSEcCtD
Abacavir—ADH6—Metabolism—PSMA4—liver cancer	0.000589	0.00239	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PSMD10—liver cancer	0.000589	0.00239	CbGpPWpGaD
Abacavir—Connective tissue disorder—Epirubicin—liver cancer	0.000588	0.00249	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000583	0.00247	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000578	0.00234	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GOT2—liver cancer	0.000573	0.00232	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000566	0.00229	CbGpPWpGaD
Abacavir—Erythema multiforme—Epirubicin—liver cancer	0.000566	0.0024	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—liver cancer	0.000554	0.00235	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.00055	0.00223	CbGpPWpGaD
Abacavir—Pharyngitis—Doxorubicin—liver cancer	0.000549	0.00233	CcSEcCtD
Abacavir—ADK—Metabolism—GLUL—liver cancer	0.000547	0.00222	CbGpPWpGaD
Abacavir—ADK—Metabolism—CPT1B—liver cancer	0.000547	0.00222	CbGpPWpGaD
Abacavir—Connective tissue disorder—Doxorubicin—liver cancer	0.000544	0.00231	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—liver cancer	0.00054	0.00229	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP2E1—liver cancer	0.000538	0.00218	CbGpPWpGaD
Abacavir—Chills—Epirubicin—liver cancer	0.000537	0.00228	CcSEcCtD
Abacavir—Alopecia—Epirubicin—liver cancer	0.000529	0.00224	CcSEcCtD
Abacavir—ADK—Metabolism—NR1H4—liver cancer	0.000528	0.00214	CbGpPWpGaD
Abacavir—Erythema multiforme—Doxorubicin—liver cancer	0.000523	0.00222	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—liver cancer	0.000521	0.00221	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GGT1—liver cancer	0.000521	0.00211	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTA3—liver cancer	0.000519	0.0021	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYCS—liver cancer	0.000504	0.00204	CbGpPWpGaD
Abacavir—Immune system disorder—Doxorubicin—liver cancer	0.0005	0.00212	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP2E1—liver cancer	0.000497	0.00202	CbGpPWpGaD
Abacavir—Chills—Doxorubicin—liver cancer	0.000497	0.00211	CcSEcCtD
Abacavir—ADH6—Metabolism—GOT1—liver cancer	0.000494	0.002	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GGT1—liver cancer	0.000494	0.002	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000491	0.00199	CbGpPWpGaD
Abacavir—Alopecia—Doxorubicin—liver cancer	0.000489	0.00208	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—liver cancer	0.000483	0.00205	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—liver cancer	0.000482	0.00204	CcSEcCtD
Abacavir—Anaemia—Epirubicin—liver cancer	0.000481	0.00204	CcSEcCtD
Abacavir—ADK—Metabolism—GSTA4—liver cancer	0.000475	0.00192	CbGpPWpGaD
Abacavir—Malaise—Epirubicin—liver cancer	0.00047	0.00199	CcSEcCtD
Abacavir—Vertigo—Epirubicin—liver cancer	0.000468	0.00198	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—liver cancer	0.000468	0.0019	CbGpPWpGaD
Abacavir—Leukopenia—Epirubicin—liver cancer	0.000466	0.00198	CcSEcCtD
Abacavir—ADK—Metabolism—GSTA2—liver cancer	0.000462	0.00187	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HMOX1—liver cancer	0.000461	0.00187	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GGT1—liver cancer	0.000457	0.00185	CbGpPWpGaD
Abacavir—Cough—Epirubicin—liver cancer	0.000454	0.00193	CcSEcCtD
Abacavir—Convulsion—Epirubicin—liver cancer	0.000451	0.00191	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—liver cancer	0.000447	0.0019	CcSEcCtD
Abacavir—ADK—Metabolism—GSTA1—liver cancer	0.000446	0.00181	CbGpPWpGaD
Abacavir—Anaemia—Doxorubicin—liver cancer	0.000445	0.00189	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTP1—liver cancer	0.000444	0.0018	CbGpPWpGaD
Abacavir—Myalgia—Epirubicin—liver cancer	0.000443	0.00188	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—liver cancer	0.000443	0.00188	CcSEcCtD
Abacavir—Anxiety—Epirubicin—liver cancer	0.000442	0.00187	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000441	0.00179	CbGpPWpGaD
Abacavir—ADK—Metabolism—NAT2—liver cancer	0.000441	0.00179	CbGpPWpGaD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00044	0.00187	CcSEcCtD
Abacavir—Discomfort—Epirubicin—liver cancer	0.000438	0.00186	CcSEcCtD
Abacavir—ADH6—Metabolism—HMOX1—liver cancer	0.000438	0.00177	CbGpPWpGaD
Abacavir—Malaise—Doxorubicin—liver cancer	0.000435	0.00184	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—liver cancer	0.000433	0.00184	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—liver cancer	0.000431	0.00183	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—HGF—liver cancer	0.00043	0.00174	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—liver cancer	0.00043	0.00174	CbGpPWpGaD
Abacavir—Oedema—Epirubicin—liver cancer	0.000425	0.0018	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—liver cancer	0.000425	0.0018	CcSEcCtD
Abacavir—ADK—Metabolism—ALDOB—liver cancer	0.000423	0.00171	CbGpPWpGaD
Abacavir—Infection—Epirubicin—liver cancer	0.000422	0.00179	CcSEcCtD
Abacavir—Cough—Doxorubicin—liver cancer	0.000421	0.00178	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—liver cancer	0.000418	0.00177	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—liver cancer	0.000417	0.00177	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—liver cancer	0.000416	0.00177	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—liver cancer	0.000413	0.00175	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000412	0.00167	CbGpPWpGaD
Abacavir—Arthralgia—Doxorubicin—liver cancer	0.00041	0.00174	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—liver cancer	0.00041	0.00174	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTP1—liver cancer	0.00041	0.00166	CbGpPWpGaD
Abacavir—Anxiety—Doxorubicin—liver cancer	0.000409	0.00173	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTM1—liver cancer	0.000408	0.00165	CbGpPWpGaD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000407	0.00173	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—liver cancer	0.000405	0.00172	CcSEcCtD
Abacavir—Anorexia—Epirubicin—liver cancer	0.000405	0.00172	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—liver cancer	0.000405	0.00164	CbGpPWpGaD
Abacavir—ADK—Metabolism—CRABP1—liver cancer	0.000403	0.00164	CbGpPWpGaD
Abacavir—Hypotension—Epirubicin—liver cancer	0.000397	0.00168	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—liver cancer	0.000393	0.00167	CcSEcCtD
Abacavir—Oedema—Doxorubicin—liver cancer	0.000393	0.00167	CcSEcCtD
Abacavir—Infection—Doxorubicin—liver cancer	0.000391	0.00166	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000387	0.00164	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP1A1—liver cancer	0.000387	0.00157	CbGpPWpGaD
Abacavir—Nervous system disorder—Doxorubicin—liver cancer	0.000386	0.00164	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—liver cancer	0.000385	0.00163	CcSEcCtD
Abacavir—Insomnia—Epirubicin—liver cancer	0.000384	0.00163	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—liver cancer	0.000382	0.00162	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—liver cancer	0.000382	0.00162	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—liver cancer	0.000379	0.00161	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTM1—liver cancer	0.000377	0.00153	CbGpPWpGaD
Abacavir—Anorexia—Doxorubicin—liver cancer	0.000375	0.00159	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—liver cancer	0.000372	0.00151	CbGpPWpGaD
Abacavir—Decreased appetite—Epirubicin—liver cancer	0.000369	0.00157	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—liver cancer	0.000367	0.00156	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000367	0.00156	CcSEcCtD
Abacavir—Fatigue—Epirubicin—liver cancer	0.000366	0.00155	CcSEcCtD
Abacavir—Pain—Epirubicin—liver cancer	0.000363	0.00154	CcSEcCtD
Abacavir—ADH6—Metabolism—MTHFR—liver cancer	0.000361	0.00146	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000358	0.00152	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP1A1—liver cancer	0.000357	0.00145	CbGpPWpGaD
Abacavir—Insomnia—Doxorubicin—liver cancer	0.000356	0.00151	CcSEcCtD
Abacavir—ADH6—Metabolism—PPARA—liver cancer	0.000354	0.00143	CbGpPWpGaD
Abacavir—Paraesthesia—Doxorubicin—liver cancer	0.000353	0.0015	CcSEcCtD
Abacavir—ADK—Metabolism—HPGDS—liver cancer	0.000353	0.00143	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000352	0.00143	CbGpPWpGaD
Abacavir—Dyspnoea—Doxorubicin—liver cancer	0.000351	0.00149	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—liver cancer	0.00035	0.00149	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—liver cancer	0.000348	0.00147	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—liver cancer	0.000342	0.00145	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00034	0.00144	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—liver cancer	0.000339	0.00144	CcSEcCtD
Abacavir—Urticaria—Epirubicin—liver cancer	0.000338	0.00143	CcSEcCtD
Abacavir—Pain—Doxorubicin—liver cancer	0.000336	0.00143	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—liver cancer	0.000336	0.00143	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—liver cancer	0.000336	0.00143	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—liver cancer	0.000324	0.00137	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000322	0.00136	CcSEcCtD
Abacavir—ADK—Metabolism—PSMD10—liver cancer	0.000314	0.00127	CbGpPWpGaD
Abacavir—ADK—Metabolism—PSMA4—liver cancer	0.000314	0.00127	CbGpPWpGaD
Abacavir—Hypersensitivity—Epirubicin—liver cancer	0.000313	0.00133	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—liver cancer	0.000312	0.00133	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—liver cancer	0.000311	0.00132	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—liver cancer	0.000311	0.00132	CcSEcCtD
Abacavir—ADK—Metabolism—GOT2—liver cancer	0.000306	0.00124	CbGpPWpGaD
Abacavir—Asthenia—Epirubicin—liver cancer	0.000305	0.00129	CcSEcCtD
Abacavir—ADH6—Metabolism—PIK3CG—liver cancer	0.000303	0.00123	CbGpPWpGaD
Abacavir—Pruritus—Epirubicin—liver cancer	0.000301	0.00128	CcSEcCtD
Abacavir—ADH6—Metabolism—PPARG—liver cancer	0.000292	0.00119	CbGpPWpGaD
Abacavir—Diarrhoea—Epirubicin—liver cancer	0.000291	0.00123	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—liver cancer	0.00029	0.00123	CcSEcCtD
Abacavir—ADK—Metabolism—CYP2E1—liver cancer	0.000287	0.00117	CbGpPWpGaD
Abacavir—Asthenia—Doxorubicin—liver cancer	0.000282	0.0012	CcSEcCtD
Abacavir—Dizziness—Epirubicin—liver cancer	0.000281	0.00119	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—liver cancer	0.000278	0.00118	CcSEcCtD
Abacavir—Vomiting—Epirubicin—liver cancer	0.00027	0.00115	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—liver cancer	0.000269	0.00114	CcSEcCtD
Abacavir—ADK—Metabolism—CYCS—liver cancer	0.000269	0.00109	CbGpPWpGaD
Abacavir—Rash—Epirubicin—liver cancer	0.000268	0.00114	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—liver cancer	0.000268	0.00114	CcSEcCtD
Abacavir—UGT1A1—Metabolism—UGDH—liver cancer	0.000267	0.00108	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CD—liver cancer	0.000266	0.00108	CbGpPWpGaD
Abacavir—Headache—Epirubicin—liver cancer	0.000266	0.00113	CcSEcCtD
Abacavir—ADK—Metabolism—GOT1—liver cancer	0.000264	0.00107	CbGpPWpGaD
Abacavir—ADK—Metabolism—GGT1—liver cancer	0.000264	0.00107	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALB—liver cancer	0.000263	0.00107	CbGpPWpGaD
Abacavir—Dizziness—Doxorubicin—liver cancer	0.00026	0.0011	CcSEcCtD
Abacavir—Nausea—Epirubicin—liver cancer	0.000252	0.00107	CcSEcCtD
Abacavir—UGT1A1—Metabolism—EPT1—liver cancer	0.000251	0.00102	CbGpPWpGaD
Abacavir—Vomiting—Doxorubicin—liver cancer	0.00025	0.00106	CcSEcCtD
Abacavir—Rash—Doxorubicin—liver cancer	0.000248	0.00105	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—liver cancer	0.000248	0.00105	CcSEcCtD
Abacavir—Headache—Doxorubicin—liver cancer	0.000246	0.00105	CcSEcCtD
Abacavir—UGT1A1—Metabolism—TAT—liver cancer	0.000238	0.000965	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTP1—liver cancer	0.000237	0.000961	CbGpPWpGaD
Abacavir—ADK—Metabolism—HMOX1—liver cancer	0.000234	0.000948	CbGpPWpGaD
Abacavir—Nausea—Doxorubicin—liver cancer	0.000234	0.000991	CcSEcCtD
Abacavir—ADH6—Metabolism—PIK3CB—liver cancer	0.000232	0.000941	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTM1—liver cancer	0.000218	0.000883	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP1A1—liver cancer	0.000207	0.000837	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTHFR—liver cancer	0.000193	0.00078	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPARA—liver cancer	0.000189	0.000766	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—liver cancer	0.000175	0.00071	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CPT1B—liver cancer	0.000162	0.000656	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GLUL—liver cancer	0.000162	0.000656	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CG—liver cancer	0.000162	0.000656	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NR1H4—liver cancer	0.000156	0.000633	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPARG—liver cancer	0.000156	0.000633	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTA3—liver cancer	0.000154	0.000622	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CD—liver cancer	0.000142	0.000576	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CA—liver cancer	0.000142	0.000574	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTA4—liver cancer	0.00014	0.000569	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—liver cancer	0.00014	0.000569	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTA2—liver cancer	0.000137	0.000554	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTA1—liver cancer	0.000132	0.000535	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NAT2—liver cancer	0.000131	0.000529	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALDOB—liver cancer	0.000125	0.000507	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CB—liver cancer	0.000124	0.000502	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CRABP1—liver cancer	0.000119	0.000484	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKT1—liver cancer	0.000116	0.000469	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HPGDS—liver cancer	0.000104	0.000423	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PSMA4—liver cancer	9.3e-05	0.000377	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PSMD10—liver cancer	9.3e-05	0.000377	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GOT2—liver cancer	9.05e-05	0.000367	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP2E1—liver cancer	8.51e-05	0.000345	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYCS—liver cancer	7.96e-05	0.000323	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GOT1—liver cancer	7.81e-05	0.000316	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GGT1—liver cancer	7.81e-05	0.000316	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CA—liver cancer	7.56e-05	0.000306	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTP1—liver cancer	7.02e-05	0.000284	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HMOX1—liver cancer	6.92e-05	0.00028	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—liver cancer	6.45e-05	0.000261	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKT1—liver cancer	6.17e-05	0.00025	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP1A1—liver cancer	6.11e-05	0.000248	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTHFR—liver cancer	5.7e-05	0.000231	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPARA—liver cancer	5.59e-05	0.000227	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CG—liver cancer	4.79e-05	0.000194	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPARG—liver cancer	4.62e-05	0.000187	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CD—liver cancer	4.21e-05	0.000171	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—liver cancer	4.15e-05	0.000168	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CB—liver cancer	3.67e-05	0.000149	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CA—liver cancer	2.24e-05	9.06e-05	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKT1—liver cancer	1.83e-05	7.4e-05	CbGpPWpGaD
